Skip to main content
Premium Trial:

Request an Annual Quote

Aros to Provide Sequence Analysis on CLC Bio's Platform

Premium

European sequencing service provider Aros Applied Biotechnology is now offering its customers the option to receive their next-gen sequencing data in CLC Bio's format. Customers will also receive a time-limited license for the CLC Genomics Workbench.

The deal covers all steps, including extraction, sample banking, and analysis and advanced bioinformatics.

The two companies are also collaborating with other organizations in a $5 million sequence analysis project of formalin fixed, paraffin embedded tissues samples (IS 9/14/2010).

Financial terms of the recent deal were not disclosed.

The Scan

Study Finds Few FDA Post-Market Regulatory Actions Backed by Research, Public Assessments

A Yale University-led team examines in The BMJ safety signals from the US FDA Adverse Event Reporting System and whether they led to regulatory action.

Duke University Team Develops Programmable RNA Tool for Cell Editing

Researchers have developed an RNA-based editing tool that can target specific cells, as they describe in Nature.

Novel Gene Editing Approach for Treating Cystic Fibrosis

Researchers in Science Advances report on their development of a non-nuclease-based gene editing approach they hope to apply to treat cystic fibrosis.

Study Tracks Responses in Patients Pursuing Polygenic Risk Score Profiling

Using interviews, researchers in the European Journal of Human Genetics qualitatively assess individuals' motivations for, and experiences with, direct-to-consumer polygenic risk score testing.